Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
Open Access
- 1 April 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in Patient Preference and Adherence
- Vol. ume 7, 275-284
- https://doi.org/10.2147/ppa.s41609
Abstract
Purpose: There is strong evidence supporting the link between nonadherence to antipsychotic medication and relapse of schizophrenia. However, less obvious are the economic consequences of nonadherence. The systematic review reported here evaluated the economic aspects of nonadherence to antipsychotic medication. Methods: A systematic review of scientific papers in the PubMed MEDLINE, Embase, PsychINFO, BIOSIS, and Evidence-Based Medicine Reviews databases was undertaken. Studies that measured adherence to antipsychotic medication and that provided comparative information on health care costs were included. Results: Eight studies met the inclusion criteria. All were observational. Despite the differences between the studies in terms of design, adherence measures, and cost components analyzed, the results of this systematic review indicate that nonadherence to antipsychotic medication is associated with increased hospitalization rates and resource utilization, resulting in increased direct health care costs. Conclusion: Nonadherence to antipsychotic medication results in poor health and economic outcomes; therefore, the authors suggest endorsing interventions aimed at improving adherence because they can improve patient health without substantially increasing costs.Keywords
This publication has 38 references indexed in Scilit:
- Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophreniaClinicoEconomics and Outcomes Research, 2011
- The cost of relapse and the predictors of relapse in the treatment of schizophreniaBMC Psychiatry, 2010
- Cost of treatment of schizophrenia in six European countriesSchizophrenia Research, 2009
- Medication adherence levels and differential use of mental-health services in the treatment of schizophreniaBMC Research Notes, 2009
- Outpatient Antipsychotic Treatment and Inpatient Costs of SchizophreniaSchizophrenia Bulletin, 2007
- The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with SchizophreniaAdministration and Policy in Mental Health and Mental Health Services Research, 2007
- Defining and Assessing Adherence to Oral Antipsychotics: A Review of the LiteratureSchizophrenia Bulletin, 2005
- Increased suicide attempt rate among patients interrupting use of atypical antipsychoticsPharmacoepidemiology and Drug Safety, 2003
- Mental Disorder and Criminality: Male SchizophreniaSchizophrenia Bulletin, 1996